Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q1 2014 · 10-Q
Revenue$1.48M$1.48M−2.1% vs Q1 2013 Net Income-$5.97M-$5.97MN/M vs Q1 2013 EPS Diluted-$0.18-$0.18N/M vs Q1 2013 Gross Profit$857,000+2.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flow-$3,709,000N/M Free Cash Flowderived-$3,722,000N/M Margins · derivedGross margin57.8%+2.3 pt vs Q1 2013
Operating margin-373.5%−161.4 pt vs Q1 2013
Net margin-402.7%−80.0 pt vs Q1 2013
ended Mar 31, 2014 · filed May 7, 2014 · 37 d after period end